A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy

MLA

Eduardo Alegría, et al. A Review of the Evidence on Reducing Macrovascular Risk in Patients with Atherogenic Dyslipidaemia: A Report from an Expert Consensus Meeting on the Role of Fenofibrate-Statin Combination Therapy. Jan. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bb64a853088529eb19796e49083d1c19&authtype=sso&custid=ns315887.

APA

Eduardo Alegría, Meral Kayıkçıoğlu, Alberto Mello e Silva, Jesús Millán, Željko Reiner, Margus Viigimaa, Moses Elisaf, Nicolae Hancu, Michal Vrablík, Alberico L. Catapano, Paul Valensi, Francesco Cosentino, Pasquale Perrone Filardi, Roberto Ferrari, Riccardo C. Bonadonna, Jean Ferrières, José Luis Zamorano, Alberto Zambon, Lale Tokgozoglu, … Michel Farnier. (2015). A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.

Chicago

Eduardo Alegría, Meral Kayıkçıoğlu, Alberto Mello e Silva, Jesús Millán, Željko Reiner, Margus Viigimaa, Moses Elisaf, et al. 2015. “A Review of the Evidence on Reducing Macrovascular Risk in Patients with Atherogenic Dyslipidaemia: A Report from an Expert Consensus Meeting on the Role of Fenofibrate-Statin Combination Therapy,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bb64a853088529eb19796e49083d1c19&authtype=sso&custid=ns315887.